HI
CRL icon

Harbour Investments’s Charles River Laboratories CRL Stock Holding History

Harbour Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21K Buy
122
+71
+139% +$13.2K ﹤0.01% 2860
2025
Q4 		$10.2K Sell
51
-1
-2% -$181 ﹤0.01% 2736
2025
Q3 		$8.14K Buy
52
+2
+4% +$318 ﹤0.01% 2783
2025
Q2 		$7.59K Sell
50
-6
-11% -$800 ﹤0.01% 2692
2025
Q1 		$8.43K Sell
56
-4
-7% -$671 ﹤0.01% 2601
2024
Q4 		$11.1K Hold
60
– – ﹤0.01% 2399
2024
Q3 		$11.8K Buy
60
+10
+20% +$2.08K ﹤0.01% 2283
2024
Q2 		$10.3K Buy
50
+20
+67% +$4.53K ﹤0.01% 2250
2024
Q1 		$8.13K Buy
30
+1
+3% +$239 ﹤0.01% 2300
2023
Q4 		$6.86K Sell
29
-9
-24% -$1.77K ﹤0.01% 2299
2023
Q3 		$7.45K Sell
38
-3
-7% -$616 ﹤0.01% 2143
2023
Q2 		$8.62K Sell
41
-15
-27% -$2.98K ﹤0.01% 2101
2023
Q1 		$11.3K Sell
56
-9
-14% -$2.04K ﹤0.01% 1961
2022
Q4 		$14.2K Buy
65
+14
+27% +$3.06K ﹤0.01% 1812
2022
Q3 		$11K Hold
51
– – ﹤0.01% 1880
2022
Q2 		$11K Buy
+51
New +$12.5K ﹤0.01% 1880
2021
Q4 		$14K Sell
36
-119
-77% -$46.2K ﹤0.01% 1795
2021
Q3 		$64K Buy
155
+32
+26% +$13.3K ﹤0.01% 1616
2021
Q2 		$46K Sell
123
-23
-16% -$7.68K ﹤0.01% 1860
2021
Q1 		$42K Buy
+146
New +$40.6K ﹤0.01% 1786

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Harbour Investments's CRL Position: Q1 2026 in Review

Harbour Investments increased its Charles River Laboratories (CRL) stake by 139% in Q1 2026, buying an estimated $13.2K and bringing the position to 122 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #2860.

Harbour Investments first reported a position in CRL in Q1 2021 and has held it in 20 quarters since. The position peaked at $64K in Q3 2021. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Harbour Investments held 122 shares of Charles River Laboratories worth $21K as of Q1 2026.
  • Harbour Investments bought 71 Charles River Laboratories shares in Q1 2026, an estimated $13.2K.
  • Charles River Laboratories made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #2860 holding.
  • Harbour Investments first reported a position in Charles River Laboratories in Q1 2021 and has held it in 20 quarters since.
  • Harbour Investments's Charles River Laboratories position peaked at $64K in Q3 2021.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.